For citations:
Ibragimova M.K., Kravtsova E.A., Tsyganov M.M., Litviakov N.V. CNA landscape of HER2-negative breast cancer during administration of taxane-containing schemes of neoadjuvant chemotherapy. Advances in Molecular Oncology. 2025;12(1):53-60. (In Russ.) https://doi.org/10.17650/2313-805X-2025-12-1-53-60